Emergent Biosolutions Inc. buy Quitte
Start price
18.12.17
/
50%
€41.75
Target price
08.03.18
€46.90
Performance (%)
12.99%
End price
08.03.18
€47.18
Summary
This prediction ended on 08.03.18 with a price of €47.18. The BUY prediction by Quitte finished with a performance of 12.99%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Emergent Biosolutions Inc. | -0.786% | -0.786% | 34.872% | -22.529% |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% | 54.489% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% | 85.552% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% | 55.407% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% | 62.988% |
Comments by Quitte for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
langsam, aber stetig
aufwärts.
Außerdem eine Zacks-Empfehlung - denen ich jedoch nicht blind zu folgen gedenke, wie z.B. bei Peregrine, die mit Zacks#4 bewertet wird.
Hier überzeugt mich der Chart.